Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5119-5128

  Yuan, Hong ^a   Bao, Xin ^a   Du, Yong Zhong ^a   You, Jian ^a   Hu, Fu Qiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Doxorubicin; Nanoparticles; SiO2 deposited; Stearic acid g chitosan

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHITOSAN; COPOLYMER; DOXORUBICIN; NANOPARTICLE; SILICON DIOXIDE; STEARIC ACID; NANOCAPSULE; STEARIC ACID DERIVATIVE;

ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG RELEASE; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; IN VITRO STUDY; MICELLE; NANOANALYSIS; NANOPHARMACEUTICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY; ZETA POTENTIAL; ADSORPTION; CHEMISTRY; DIFFUSION; LUNG TUMOR; METABOLISM; TUMOR CELL LINE; ULTRASTRUCTURE;

ADSORPTION; CELL LINE, TUMOR; CHITOSAN; DIFFUSION; DOXORUBICIN; HUMANS; LUNG NEOPLASMS; NANOCAPSULES; SILICON DIOXIDE; STEARIC ACIDS;

EID: 84870351315     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S35575     Document Type: Article

References (23)

1. Orive G, Hernández RM, Gascón AR, Pedraz JL. Micro and nano drug delivery systems in cancer therapy. Cancer Therapy. 2005;3: 131-138.
2. Webber SE. Polymer micelles: an example of self-assembling polymers. J Phys Chem B. 1998;102(15):2618-2626.
3. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271-284.
4. Matsumura Y, Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci. 2009;100(4): 572-579.
5. Husseini GA, Pitt WG. Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Deliv Rev. 2008;60(10):1137-1152.
6. Hu FQ, Meng P, Dai YQ, etal. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm. 2008;70(3):749-757.
7. Huang MH, Chou AH, Lien SP, etal. Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactideco-epsilon-caprolactone). J Biomed Mater Res B Appl Biomater. 2009;90(2):832-841.
8. Bernkop-Schnürch A, Krajicek ME. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Control Release. 1998;50(1-3):215-223.
9. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature. 1992;359(6397):710-712.
10. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60(11):1278-1288.
11. Slowing II, Trewyn BG, Giri S, Lin VSY. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc. 2007;129(28):8845-8849.
12. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VS. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc. 2004;126(41): 13216-13217.
13. Simovic S, Heard P, Hui H, etal. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol Pharm. 2009;6(3): 861-872.
14. Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J Control Release. 2009;134(1):62-70.
15. Dwivedi N, Arunagirinathan MA, Sharma S, Bellare J. Silica-coated liposomes for insulin delivery. J Nanomat. 2010;652048.
16. Mohanraj VJ, Barnes TJ, Prestidge CA. Silica nanoparticle coated liposomes: A new type of hybrid nanocapsule for proteins. Int J Pharm. 2010;392(1):285-293.
17. Hu FQ, Ren GF, Yuan H, Du YZ, Zeng S, etal. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B Biointerfaces. 2006;50(2):97-103.
18. Wen J, Wilkes GL. Organic/inorganic hybrid network materials by the sol-gel approach. Chem Mater. 1996;8(8):1667-1681.
19. Li Y, Hu FQ, Yuan H. Preparation and release profiles of chitosan oligosaccharide grafted stearic acid nanoparticles in vitro. Chinese Pharm J. 2005;40(14):1083.
20. Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res. 2002;19(10):1488-1494.
21. Pieper JS, Hafmans T, Veerkamp JH, Kuppevelt TH. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials. 2000;21(6): 581-593.
22. Hu FQ, Zhao MD, Yuan H, You J, Du YZ, Zeng S. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm. 2006;315(1-2):158-166.
23. Kohori F, Yokoyama M, Sakai K, Okano T. Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. J Control Release. 2002;78(1-3):155-163.